hMSC Production in Disposable Bioreactors with Regards to GMP and PAT

被引:29
作者
Cierpka, Katharina [1 ]
Elseberg, Christiane L. [1 ]
Niss, Knut [2 ]
Kassem, Moustapha [3 ,4 ]
Salzig, Denise [1 ]
Czermak, Peter [1 ,5 ]
机构
[1] Univ Appl Sci Mittelhessen, Inst Bioproc Engn & Pharmaceut Technol, D-35390 Giessen, Germany
[2] EMD Millipore Corp, Bedford, MA 01730 USA
[3] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark
[4] King Saud Univ, Dept Anat, Stem Cell Unit, Riyadh, Saudi Arabia
[5] Kansas State Univ, Dept Chem Engn, Manhattan, KS 66506 USA
关键词
Disposable reactor; Fixed-bed reactor; hMSC; Stem cell production; Stirred-tank reactor; MESENCHYMAL STEM-CELLS; NONPOROUS GLASS CARRIER; LARGE-SCALE PRODUCTION; BONE-MARROW; CULTIVATION SYSTEM; MAMMALIAN-CELLS; STROMAL CELLS; IN-VITRO; EXPANSION; MICROCARRIER;
D O I
10.1002/cite.201200151
中图分类号
TQ [化学工业];
学科分类号
081705 [工业催化];
摘要
Reactor concepts for human mesenchymal stem cell (hMSC) production are introduced. Thereby, special interest is laid on the realization of these concepts as disposables fulfilling the GMP and PAT requirements. The specialty of the hMSC production process is the cell itself being the product. This results in completely different process requirements compared to e.g. protein production in mammalian cells. Thus, great attention has to be given to the shear sensitivity of the cells. The cultivation and the harvest of the cells have to be very gentle to neither influence cell viability nor cell differentiability. Further, the production process should not cause any undesirable cell changes. For hMSC production, cell harvest is the main challenging process step. The reactor concepts should be suitable for hMSC production for clinical trials as ATMPs. Therefore, disposable systems are especially applicable. The review describes more detailed bone marrow-derived hMSC production in a disposable stirred tank reactor as promising reactor concept.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 61 条
[1]
Akerstrom H., 2009, DEGREE PROJECT
[2]
Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion [J].
Baksh, D ;
Davies, JE ;
Zandstra, PW .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (08) :723-732
[3]
Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives [J].
Baldi, Lucia ;
Hacker, David L. ;
Adam, Myriam ;
Wurm, Florian M. .
BIOTECHNOLOGY LETTERS, 2007, 29 (05) :677-684
[5]
Cell sheet detachment affects the extracellular matrix: A surface science study comparing thermal liftoff, enzymatic, and mechanical methods [J].
Canavan, HE ;
Cheng, XH ;
Graham, DJ ;
Ratner, BD ;
Castner, DG .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 75A (01) :1-13
[6]
Three-dimensional culture of human mesenchymal stem cells in a polyethylene terephthalate matrix [J].
Cao, Yanfen ;
Li, Ding ;
Shang, Chunhua ;
Yang, Shang-Tian ;
Wang, Jufang ;
Wang, Xiaoning .
BIOMEDICAL MATERIALS, 2010, 5 (06)
[7]
Mesenchymal stem cells: building blocks for molecular medicine in the 21st century [J].
Caplan, AI ;
Bruder, SP .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) :259-264
[8]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[9]
Duennebier G, 2007, CHEM-ING-TECH, V79, P2019, DOI 10.1002/cite.200700156
[10]
Eibl R., 2008, Cell and Tissue Reaction Engineering